JPRN-UMIN000048007招募中未知
efficacy and safety of Ultra low dose oral immunotherapy for severe nut allergy; open label multi centered observational study - ULDOIT for severe peanut and nut(walnut) allergy
Yokohama Nishikage Clinic: kids and allergies0 个研究点目标入组 20 人开始时间: 2022年6月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 3years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •the subjects who have the conditions bellow 1.poorly controlled atopic dermatitis 2.poorly controlled asthma 3.immunodeficiency 4.taking beta blockers 5. pregnancy 6. taking medications for psychiatric disorders except child developmental disorders 7.malignant diseases
研究者
相似试验
招募中
Unknown
Safety and Efficacy of slow low-dose oral immunotherapy Shimane version for patients with positive low-dose oral food challengefood allergyJPRN-UMIN000049359Department of Pediatrics, Shimane University School of Medicine200
招募中
不适用
Efficacy and safety of low-dose oral immunotherapy with heated milk powder in patients with severe milk allergyfood allergyJPRN-UMIN000046749ational Hospital Organization Sagamihara National Hospital20
已完成
3 期
Clinical efficacy and safety of sublingual immunotherapy in patients with Japanese cedar pollinosis.A double-blind,placebo-controlled study.Japanese cedar pollinosisJPRN-UMIN000000709Department of Otorhinolaryngology in Ciba University Graduate School150
进行中（未招募）
1 期
Efficacy and safety of the fixed oral low-dose perindopril arginine 3.5 mg/amlodipine 2.5 mg combination compared with each component (perindopril arginine 3.5 mg and amlodipine 2.5 mg) and with perindopril arginine 5 mg and amlodipine 5 mg.Randomized, double-blind, placebo-controlled study over 8 weeks in hypertensive patients.EUCTR2006-005797-44-HUInstitut de Recherches Internationales Servier1,500
进行中（未招募）
不适用
Efficacy and safety of the fixed oral low-dose perindopril arginine 3.5 mg/amlodipine 2.5 mg combination compared with each component (perindopril arginine 3.5 mg and amlodipine 2.5 mg) and with perindopril arginine 5 mg and amlodipine 5 mg.Randomized, double-blind, placebo-controlled study over 8 weeks in hypertensive patients.Essential arterial hypertensionMedDRA version: 8.1Level: LLTClassification code 10020775Term: Hypertension arterialEUCTR2006-005797-44-LTInstitut de Recherches Internationales Servier1,500